Network Pharmacology and In Vivo Validation Reveal Berberine-Mediated Regulation of the Liver–Brain Inflammatory Axis in MCD-Induced Steatohepatitis
International Journal of Molecular Sciences · 03.08.2026 · 27 (15) · 6967
DOI: 10.3390/ijms27156967 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.08.2026. Verfasst von Yeon-Joo Yoo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Korean Medicine, Graduate School, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea. Hauptthemen laut MEDLINE: Berberine, Liver, Brain, Fatty Liver. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Health Industry Development Institute, Korea Health Technology R&D Project.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive immunometabolic liver disorder involving lipid dysregulation, inflammation, fibrosis, and extrahepatic immune–neural responses, yet therapies capable of modulating these interconnected processes remain limited. Berberine (BBR), an isoquinoline alkaloid derived from traditional medicinal plants including Coptis chinensis Franch. (Coptidis Rhizoma), has shown metabolic and anti-inflammatory activities; however, its effects on hepatic inflammation and the liver–brain inflammatory axis in MASH remain unclear. Here, network pharmacology and molecular docking were used to predict BBR targets and pathways, followed by in vivo validation in a methionine- and choline-deficient diet-induced mouse model. Liver injury and metabolic alterations were assessed using serum biochemistry and lipid profiles, histological changes by hematoxylin and eosin and Sirius Red staining, and hepatic and hypothalamic inflammation by qRT-PCR, flow cytometry, and Iba-1/GFAP immunostaining. SREBF1, AKT1, and TGFB1 were identified as core BBR targets, with pathways linked to lipid metabolism, oxidative stress, inflammation, and fibrogenesis. BBR attenuated liver injury, steatosis, steatohepatitis, and fibrosis, suppressed SREBF1-associated lipogenic signaling and fibrogenic gene expression, remodeled circulating monocyte subsets, reduced Kupffer cell accumulation, and inhibited hypothalamic microglial activation. These findings suggest that BBR alleviates MCD-induced steatohepatitis through multi-target regulation of hepatic metabolic dysfunction, immune remodeling, and hypothalamic neuroinflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Korean Medicine, Graduate School, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea.
- Department of Nephrology & Endocrinology, Kyung Hee University Korean Medicine Hospital, Kyung Hee Medical Center, 23 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea.
ORCID-Profile: Yeon-Joo Yoo, Ji-Han Kim, Byung-Cheol Lee
Förderung
- Korea Health Industry Development Institute
- Korea Health Technology R&D Project
Zitieren
APA
Yoo, Y. J., Kim, J. H., Yoo, S. H., & Lee, B. C. (2026). Network Pharmacology and In Vivo Validation Reveal Berberine-Mediated Regulation of the Liver–Brain Inflammatory Axis in MCD-Induced Steatohepatitis. International Journal of Molecular Sciences, 27(15), 6967. https://doi.org/10.3390/ijms27156967
Vancouver
Yoo YJ, Kim JH, Yoo SH, Lee BC. Network Pharmacology and In Vivo Validation Reveal Berberine-Mediated Regulation of the Liver–Brain Inflammatory Axis in MCD-Induced Steatohepatitis. International Journal of Molecular Sciences. 2026;27(15):6967. doi:10.3390/ijms27156967
BibTeX
@article{Yoo2026,
author = {Yoo, Yeon-Joo and Kim, Ji-Han and Yoo, Seung-Hoon and Lee, Byung-Cheol},
title = {Network Pharmacology and In Vivo Validation Reveal Berberine-Mediated Regulation of the Liver–Brain Inflammatory Axis in MCD-Induced Steatohepatitis},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {15},
pages = {6967},
doi = {10.3390/ijms27156967}
}
EUVIMED